Delivery Order SPE2DB20D3111-SPE2DB25FA9GR
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,201.20 for Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal healthcare systems. This delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,801.80 for Trulicity 0.75 mg/0.5 ml pens on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication widely used in federal healthcare programs supporting military and veteran populations....
- The Defense Logistics Agency awarded a delivery order valued at $2,179.98 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the awardee's location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly procured through federal medical supply channels to...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens valued at $10,644.05 on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,051.05 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,305.29 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly procured by federal agencies to support military...
- The Defense Logistics Agency awarded a $1,762.92 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a injectable medication used in diabetes management, reflecting the pharmaceutical distributor's core role in...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name injectable medication commonly used in military and...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9GRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,830 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication, reflecting the critical pharmaceutical supply needs of military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a prime vendor supporting the Defense Health Agency and military healthcare programs globally, providing an extensive portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. The competitively awarded IDC positions the contractor to fulfill diverse pharmaceutical requirements for federal medical procurement across the enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/8/25 |